Eurofins deal closes at USD 400 million: Eurofins stock sits 6.14 percent above EUR 73.90 target
Published on 10/16/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSExpansion and investor calendar
- Eurofins closed the Element transaction on October 1, 2026, with expected 2026 revenue of more than USD 150 million.
- Adjusted EBITDA margin expanded by 130 basis points in the first half of 2026.
- Eurofins stock trades at EUR 78.44 at 11:00 a.m. CEST at Lang & Schwarz on October 16, 2026.
- Investor events are scheduled for October 23, 2026, and November 11, 2026.
Eurofins stock (ISIN FR0014000MR3) was trading at EUR 78.44 at Lang & Schwarz on October 16, 2026, at 11:00 a.m. CEST. Eurofins completed its acquisition of Element Materials Technology's North American Life Sciences Testing Services business on October 1, 2026, in a transaction announced at an enterprise value of USD 400 million, according to Eurofins.
What does the acquisition add?
The acquired business operates 27 laboratories and facilities and employs approximately 750 staff. It is expected to generate more than USD 150 million in annual revenue in 2026, with profitability similar to the Eurofins Group average, according to Eurofins. The operations join the BioPharma and Life businesses in North America, extending the laboratory network into regions where Eurofins said it had been underrepresented.
Eurofins results show margin progress
The chronology began with the July 20, 2026 agreement to acquire the Element business for USD 400 million. On July 23, 2026, Eurofins said first-half results showed 130 basis points of adjusted EBITDA margin expansion and 29 percent earnings-per-share growth, according to Eurofins. The acquisition then closed on October 1, 2026.
Which dates come next?
Eurofins will host an investor event in Amersfoort, Netherlands, on October 23, 2026, followed by an event in Toronto on November 11, 2026. The company investor page identifies the first-half 2026 results as published on July 23, 2026.
Stock price and target context
TradingView reported on October 5, 2026, that an analyst had cut the target for Eurofins from EUR 77.20 to EUR 73.90 and moved the view to market perform. At EUR 78.44, the Lang & Schwarz quote stands 6.14 percent above the EUR 73.90 target. The contrast puts the acquisition's revenue contribution alongside a more cautious external valuation view.
Eurofins was trading at EUR 78.44 at Lang & Schwarz on October 16, 2026, at 11:00 a.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.
Eurofins stock key data
- Company: Eurofins Scientific SE
- ISIN: FR0014000MR3
- Ticker: EUFI.PA
- Primary exchange: Euronext Paris
- Price Lang & Schwarz (as of October 16, 2026, 11:00 a.m. CEST): EUR 78.44
- Sector / Industry: Analytical testing and laboratory services
Market context: Market report CAC 40.
